News
COVID-19 Information
- 2021.04.30 COVID-19 Information Toward the Development of COVID-19 Therapeutic Agent using Bonac Nucleic Acid: Contract Research and Development Agreement with Japan Agency for Medical Research and Development (AMED) and Creation of Innovation for Clinical Empowerment (CiCLE)
- 2020.08.26 COVID-19 Information Progress in the Development of COVID-19 Therapeutic Reported at a Regular Press Conference by the Governor of Fukuoka Prefecture